Covid-19: Denmark permanently abandons AstraZeneca vaccine, a first in Europe

“The vaccination campaign in Denmark continues without [ce] vaccine”, announced the local health authority. This decision is based on the existence of “rare” but “serious” cases of thrombosis.

Article written by



Reading time : 1 min.

It is the first European country to give up the AstraZeneca vaccine for good. Denmark will no longer use this product due to its side effects “rare” But “serious”, announced the director of the National Health Agency, Søren Brostrøm, Wednesday April 14. Despite the opinions of the European regulator and the WHO in favor of its use, “the vaccination campaign in Denmark continues without the AstraZeneca vaccine”, did he declare. The approximately 150,000 people who have received a dose of this vaccine against Covid-19 will be able to benefit from another vaccine for the second injection, the authorities said.

Vaccination, evolution of the Covid-19 pandemic … Follow our live

The abandonment of this vaccine should lengthen by at least three weeks the Danish immunization program, which provided for the vaccination of all over 16 years for the month of July. Denmark was previously the first country in Europe to suspend use of the vaccine on March 11, after reports describing exceptional cases of blood clots, combined with low platelets and bleeding. Like neighboring Norway, the country had since maintained its suspension, and chose to deepen its investigation into the link between these few serious cases and vaccination. Among the injections of the AstraZeneca vaccine carried out, two cases of serious thrombosis – including one fatal – had been noted in Denmark in people previously in good health.

The AEM had finally confirmed a link with rare cases of serious thrombosis on April 8, while considering that the benefits of this vaccine still largely outweighed the risks. The majority of European countries which had suspended the use of the vaccine have resumed it, most often by setting an age limit.

Elsewhere, South Africa also gave up in February, because its effectiveness is questioned in the face of the variant which is ravaging the country. The United States, like Switzerland, has still not authorized it and Venezuela has refused to authorize it citing its side effects.

Leave a Reply

Your email address will not be published. Required fields are marked *